|
Michael B. Sheffery is a founding General Partner of OrbiMed and Co-Head of Private Equity. Dr. Sheffery was formerly Head of the Laboratory of Gene Structure and Expression at Memorial Sloan-Kettering Cancer Center. He received both his Ph.D. in Molecular Biology and his B.A. in Biology from Princeton University. Dr. Sheffery joined Mehta and Isaly in 1996 as a Senior Analyst covering the biotechnology industry. He is currently a Director of Biosynexus Incorporated, Eximias Pharmaceuticals and CoGenesys, Inc. and was formerly a Director of Biosynexus, Memory Pharmaceuticals, and NeoGenesis Pharmaceuticals. | 